A phase 2 study of high-activity 186Re-HEDP with autologous peripheral blood stem cell transplant in progressive hormone-refractory prostate cancer metastatic to bone.
PURPOSE: We investigated the potential for improvement in disease control by use of autologous peripheral blood stem cell transplant (PBSCT) to permit administration of high activities of (186)Re-hydroxyethylidene diphosphonate (HEDP) in patients with progressive hormone-refractory prostate cancer (...
Main Authors: | O'Sullivan, J, Norman, A, McCready, V, Flux, G, Buffa, F, Johnson, B, Coffey, J, Cook, G, Treleaven, J, Horwich, A, Huddart, R, Parker, C, Dearnaley, D |
---|---|
格式: | Journal article |
语言: | English |
出版: |
2006
|
相似书籍
-
High activity Rhenium-186 HEDP with autologous peripheral blood stem cell rescue: a phase I study in progressive hormone refractory prostate cancer metastatic to bone.
由: O'Sullivan, J, et al.
出版: (2002) -
A model-based method for the prediction of whole-body absorbed dose and bone marrow toxicity for 186Re-HEDP treatment of skeletal metastases from prostate cancer.
由: Buffa, F, et al.
出版: (2003) -
A Monte-Carlo method for interface dosimetry of beta emitters.
由: Buffa, F, et al.
出版: (2003) -
Challenges in treating patients with Down's syndrome and testicular cancer with chemotherapy and radiotherapy: The Royal Marsden experience.
由: Hafeez, S, et al.
出版: (2007) -
Advanced high resolution x-ray diagnostic for HEDP experiments
由: A. Y. Faenov, et al.
出版: (2018-11-01)